Cresco Labs OTC Stock Top Insiders

CRLBF Stock  USD 0.72  0.01  1.41%   
Cresco Labs employs about 3.3 K people. The company is managed by 10 executives with a total tenure of roughly 19 years, averaging almost 1.0 years of service per executive, having 330.0 employees per reported executive. Examination of Cresco Labs' management performance can provide insight into the company performance.
Charles Bachtell  CEO
CEO, Director
Thomas Manning  Chairman
Chairman of the Board
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cresco Labs. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Cresco Labs Management Team Effectiveness

The company has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0635) %, meaning that it generated substantial loss on money invested by shareholders. Cresco Labs' management efficiency ratios could be used to measure how well Cresco Labs manages its routine affairs as well as how well it operates its assets and liabilities.

Cresco Labs Workforce Comparison

Cresco Labs is rated fourth in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 24,834. Cresco Labs retains roughly 3,300 in number of employees claiming about 13% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Cresco Labs Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Cresco Labs Price Series Summation is a cross summation of Cresco Labs price series and its benchmark/peer.

Cresco Labs Notable Stakeholders

A Cresco Labs stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Cresco Labs often face trade-offs trying to please all of them. Cresco Labs' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Cresco Labs' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Charles BachtellCEO, DirectorProfile
Thomas ManningChairman of the BoardProfile
Robert SampsonCoFounder DirectorProfile
Ty GentChief OfficerProfile
John SchetzG CounselProfile
Brenna CPATreasury AccountingProfile
Zach MarburgerInterim OfficerProfile
Jake GravesMa RelationsProfile
Dennis OlisChief OfficerProfile
Impola KelliVP ComplianceProfile

About Cresco Labs Management Performance

The success or failure of an entity such as Cresco Labs often depends on how effective the management is. Cresco Labs management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Cresco management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Cresco management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. The company was founded in 2013 and is headquartered in Chicago, Illinois. Cresco Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3300 people.
The data published in Cresco Labs' official financial statements typically reflect Cresco Labs' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Cresco Labs' quantitative information. For example, before you start analyzing numbers published by Cresco accountants, it's essential to understand Cresco Labs' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.

Cresco Labs Workforce Analysis

Traditionally, organizations such as Cresco Labs use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Cresco Labs within its industry.

Cresco Labs Manpower Efficiency

Return on Cresco Labs Manpower

Revenue Per Employee249K
Revenue Per Executive82.2M
Net Loss Per Employee96.8K
Net Loss Per Executive32M

Complementary Tools for Cresco OTC Stock analysis

When running Cresco Labs' price analysis, check to measure Cresco Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cresco Labs is operating at the current time. Most of Cresco Labs' value examination focuses on studying past and present price action to predict the probability of Cresco Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cresco Labs' price. Additionally, you may evaluate how the addition of Cresco Labs to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities